Adaptimmune Therapeutics Plc (ADAP) — Free Cash Flow Generation Index
Adaptimmune Therapeutics Plc (ADAP) has a Free Cash Flow Generation Index of 0.98x as of June 2024. Free cash flow of $46.63 Million represents 1% of operating cash flow ($47.39 Million). See Adaptimmune Therapeutics Plc short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Adaptimmune Therapeutics Plc Free Cash Flow Generation Index (2013–2021)
Historical FCF Generation Index trend for Adaptimmune Therapeutics Plc across 2 annual periods. Explore Adaptimmune Therapeutics Plc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Adaptimmune Therapeutics Plc (2013–2021)
Year-by-year Free Cash Flow Generation Index for Adaptimmune Therapeutics Plc. For the full company profile including market capitalisation, see Adaptimmune Therapeutics Plc market cap and net worth.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2021 | 0.18x | $1.95 Million | $10.73 Million | $8.78 Million | ▼ -81.1% |
| 2013 | 0.96x | $35.78 Million | $37.23 Million | $1.45 Million | — |